TPM3 and cancer: Meanwhile, these TRK family members have been demonstrated to induce cancer cell growth and activate downstream signaling pathways, such as PI3K-Akt-mTOR, Ras-MAPK-ERK, and PLC-γ-Ca2 + -PKC, that potentially lead to tumorigenesis (2–6).